A Agilent Technologies Inc.

Agilent Technologies Hires Samraat “Sam” Raha to Head Strategy and Corporate Development

Agilent Technologies Inc., (NYSE: A) today announced that Samraat “Sam” Raha has been named senior vice president of strategy and corporate development, reporting to Agilent President and CEO Mike McMullen.

Raha will serve as strategic lead and advisor to the CEO and executive team in developing Agilent’s overall growth strategy, including leading its mergers and acquisitions plans globally.

“Sam shares our vision of the marketplace and knows what it takes to drive new growth,” McMullen said. “He joins us with an impressive portfolio of relevant experience in general and operational management, marketing and strategy that builds on a foundation of life sciences knowledge. He will be an excellent addition to our executive team.”

Raha joins Agilent from Illumina Inc. where he most recently served as vice president of global marketing. He was responsible for product management, clinical and corporate marketing, marketing operations and strategy. He also led the successful go-to-market strategy and launch of many impactful products, including multiple sequencing systems and consumables.

Prior to his years at Illumina, Raha was vice president and general manager of the genomic assays business unit at Life Technologies, responsible for the TaqMan™ franchise and next-generation qPCR instruments and solutions.

Before that Raha was CEO of Joby Inc., a startup that has since become a leading seller of camera accessories.

“I am delighted to be returning to Agilent, where I spent several years in my early career,” Raha said. “Agilent clearly has fantastic growth potential. The opportunity to lead its overall growth strategy and build new partnerships to further its success in high-growth markets is truly exciting, and I am eager to begin leading these efforts.”

About Agilent Technologies

Agilent Technologies Inc. (NYSE: A), a global leader in life sciences, diagnostics and applied chemical markets, is the premier laboratory partner for a better world. Agilent works with customers in more than 100 countries, providing instruments, software, services and consumables for the entire laboratory workflow. The company generated revenues of $4.20 billion in fiscal 2016 and employs about 12,500 people worldwide. Information about Agilent is available at www.agilent.com.

EN
20/03/2017

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on Agilent Technologies Inc.

Agilent Technologies, Inc.: Update to credit analysis

Our credit view of this issuer reflects its low financial leverage, against its high proportion of revenue from costly equipment sales, which has exposure to cyclical demand fluctuations

Moody's Ratings announces completion of a periodic review of ratings o...

Moody's Ratings (Moody's) has completed a periodic review of the ratings of Agilent Technologies, Inc. and other ratings that are associated with this issuer. The review was conducted through a rating committee held on 11 December 2025 in which we reassessed the appropriateness of the ratings in th...

Agilent Technologies Inc: 1 director

A director at Agilent Technologies Inc sold 2,600 shares at 149.812USD and the significance rating of the trade was 62/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two year...

Dave Nicoski ... (+2)
  • Dave Nicoski
  • Ross LaDuke

Vermilion Compass: Weekly Equity Strategy

6550-6569 S&P 500 Support Holding For Now After 5.5-months, the S&P 500 (SPX) has now failed to break and stay below the its 20-day MA. However, 6569 has been our level that needs to break in order for us to have confidence that a pullback has begun; SPX made a low of 6551 on Friday (less than 20 points or 0.3% from our 6569 level), meaning it was not a decisive breakdown (in time or price). As a result, our near-term bullish outlook since our 4/22/25 Compass remains intact, and it will stay t...

Dave Nicoski ... (+2)
  • Dave Nicoski
  • Ross LaDuke

Vital Signs: Actionable charts

In this product we rank the most positive and negative domestic stocks, filter the symbols by market-cap and trading volume, and then divide the companies into sectors and groups. We then manually look through charts leadership/changes, bottoms-up/top-down ideas, short-term patterns that may have long-term significance, etc. We believe you will find this product valuable as significant price and relative moves begin in the daily charts.

ResearchPool Subscriptions

Get the most out of your insights

Get in touch